US Military Strikes in Iran Raise Geopolitical Tensions Oil Markets on Edge Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal Why Chasing High Returns Can Backfire The Case for a Disciplined Investment Approach SpaceX Delays Starship Flight 12 to Friday Debuting V3 Rocket with Enhanced Capacity Morning Squawk Highlights Micron Milestone Dicks Earnings and Paxton Primary Upset The Pitfalls of Chasing High Returns A Cautionary Perspective Limoneira Co LMNR Q1 2026 Earnings EPS Misses Estimates by Over 42 Amid Challenging Winter Season VMC Q1 2026 Earnings Strong EPS Beat Driven by Pricing and Cost Control WSFS Q1 2026 Earnings Strong EPS Beat Driven by Core Banking Strength NGNE Q1 2026 Earnings EPS Miss Slightly Stock Rises Amid Pipeline Progress Platinum Group Metals Ltd PLG Q4 2023 Earnings NarrowerthanExpected Loss Offsets Continued Absence of Revenue VTGN Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress Kemper Corporation KMPR Declines Nearly 2 Approaching Key Support at 2578 Jerash Holdings JRSH Edges Higher as Stock Holds Above Key Support Zone Lite Strategy Inc LITS Slides 273 as Selling Pressure Mounts Near Key Support Jazz Pharmaceuticals JAZZ Experiences Modest Decline Following Recent RunUp CoDiagnostics Inc CODX Surges Over 36 Key Levels and Market Dynamics UK Police Chiefs Call for Social Media Block on Under16s Over Safety Risks Cryptocurrency Market Faces Renewed Volatility as Bitcoin and Ethereum Decline Amid Macroeconomic and Geopolitical Headwinds Dow Jones Futures Eye Geopolitical Cues as Trump Signals No Rush for Iran Deal Tesla AI Stocks Attract Attention Indian Rupee Weakens 17 Paise to 9543 Against US Dollar in Early Trade Dropbox CoFounder Andrew Houston to Step Down Insider Ashraf Alkarmi Named Successor Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment ET Alpha Wealth Summit to Address Portfolio Resilience and Alpha Generation in Mumbai BNZI Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Taysha Gene Therapies TSHA Holds Steady Near Support as Biotech Sentiment Improves